West Pharmaceutical Services Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.9% | -50.6% | +39.6% | +9.2% | +5.6% | -31.9% | +36.9% | +11.3% | +27.3% | -64.2% | +37.9% | – | |
| – | +0.6% | -0.8% | +9.3% | +3.3% | +1.2% | -3.9% | +4.3% | +5.4% | +9.3% | -5.1% | +3.6% | – | |
| – | -76.3% | +257.1% | -14.0% | +18.6% | -15.7% | -69.8% | +469.2% | +13.5% | -20.2% | -1.5% | +65.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.5% | -228.6% | – | -100.7% | – | -99.6% | -200.0% | – | +2,938.1% | -261.3% | – | – | |
| – | +13.5% | -16.7% | +10.6% | -18.9% | +29.0% | -32.0% | +5.5% | -15.8% | +20.2% | -43.9% | +1.2% | – | |
| – | -58.1% | -16.7% | +11.7% | -18.9% | +27.6% | -32.0% | +5.5% | -15.8% | +20.2% | -43.9% | +1.2% | – | |
| – | +5.7% | -0.7% | -0.7% | -0.7% | +5.5% | -0.7% | -0.7% | +0.0% | +4.6% | +0.0% | -0.6% | – | |
| – | +530.2% | +53.8% | -31.3% | -72.0% | +4.2% | +149.1% | -99.6% | -80.0% | +100.0% | +148,700.0% | – | – | |
| – | – | – | – | – | -97.1% | +100.0% | +50.0% | +0.0% | +0.0% | +0.0% | +33.3% | – | |
| – | +749.8% | +43.0% | -19.4% | -70.5% | +7.0% | +113.4% | -89.9% | -22.8% | +1.7% | +2,538.5% | -46.6% | – | |
| – | – | – | – | – | -114.1% | – | – | +12.6% | +37.0% | -265.8% | – | – | |
| – | -2.9% | -78.8% | +134.8% | +52.5% | -13.8% | -31.8% | +75.4% | +31.4% | +30.7% | -73.0% | +71.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.